Error-prone Lesion Bypass by Human DNA Polymerase Eta

YB Zhang,FH Yuan,XH Wu,O Rechkoblit,JS Taylor,NE Geacintov,ZG Wang
DOI: https://doi.org/10.1093/nar/28.23.4717
IF: 14.9
2000-01-01
Nucleic Acids Research
Abstract:DNA lesion bypass is an important cellular response to genomic damage during replication. Human DNA polymerase eta (Pol eta), encoded by the Xeroderma pigmentosum variant (XPV) gene, is known for its activity of error-free translesion synthesis opposite a TT cis-syn cyclobutane dimer. Using purified human Poly, we have examined bypass activities of this polymerase opposite several other DNA lesions. Human Pol eta efficiently bypassed a template 8-oxoguanine, incorporating an A or a C opposite the lesion with similar efficiencies. Human Pol eta effectively bypassed a template abasic site, incorporating an A and less frequently a G opposite the lesion. Significant -1 deletion was also observed when the template base 5' to the abasic site is a T. Human Poly partially bypassed a template (+)-trans-anti-benzo[a]pyrene-N-2-dG and predominantly incorporated an A, less frequently a T, and least frequently a G or a C opposite the lesion. This specificity of nucleotide incorporation correlates well with the known mutation spectrum of (+)-trans-anti-benzo[a]pyrene-N-2-dG lesion in mammalian cells. These results show that human Pol eta is capable of error-prone translesion DNA syntheses in vitro and suggest that Pol eta may bypass certain lesions with a mutagenic consequence in humans.
What problem does this paper attempt to address?